Back to Search
PETER FORSYTH, MD
MD
Neurology Physician
NPI: 1841582285IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
ME109550(FL)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 1987
Research & Publications (20)
Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience.
PMID 19669097·J Neurooncol·2010
8-other
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.
PMID 19499221·Cancer Chemother Pharmacol·2010
3-trial
Susceptibility of mantle cell lymphomas to reovirus oncolysis.
PMID 19651440·Leuk Res·2010
7-preclinical
Sciatic nerve conditioned medium depleted of pro-NGF modulates sodium currents and neurite outgrowth in PC12 cells.
PMID 19171180·Neuroscience·2009
7-preclinical
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
PMID 19544433·Stem Cells·2009
7-preclinical
A feasibility study to assess the integration of a pharmacist into neurooncology clinic.
PMID 19036905·J Oncol Pharm Pract·2009
8-other
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
PMID 19351762·Clin Cancer Res·2009
7-preclinical
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.
PMID 18398569·J Neurooncol·2008
8-other
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma.
PMID 18413825·Clin Cancer Res·2008
8-other
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
PMID 18458821·J Neurooncol·2008
3-trial
Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
PMID 18574935·Can J Neurol Sci·2008
8-other
Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
PMID 18574936·Can J Neurol Sci·2008
8-other
Methylation status of MGMT gene promoter in meningiomas.
PMID 18992637·Cancer Genet Cytogenet·2008
8-other
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.
PMID 18281557·Clin Cancer Res·2008
7-preclinical
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor.
PMID 19067488·PLoS Biol·2008
7-preclinical
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.
PMID 18253152·Mol Ther·2008
3-trial
Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
PMID 17627293·Cancer Gene Ther·2007
7-preclinical
The p75 neurotrophin receptor is a central regulator of glioma invasion.
PMID 17696644·PLoS Biol·2007
7-preclinical
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.
PMID 17875723·Cancer Res·2007
7-preclinical
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
PMID 18097886·J Neurovirol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR
TAMPA, FL 33612 - Phone
- (813) 745-4673
Quick Facts
- NPI
- 1841582285
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile